This inventor holds 2 USPTO granted patents. Top assignees: Chiron Corporation, Pharmacia & Upjohn Ab. Active years: 1998-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-1999
Title: Vibeke Arrhenius-Nyberg: Innovator in Medicinal Chemistry
Introduction
Vibeke Arrhenius-Nyberg is a notable inventor based in Järfälla, Sweden. She has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments that address protein synthesis and nitrogen balance.
Latest Patents
Vibeke holds 2 patents that focus on the use of insulin and insulin-like growth factor I (IGF-I). Her latest patent describes a combination of insulin and IGF-I used in the manufacture of a medicament aimed at counteracting a decrease in nitrogen balance and protein synthesis. This medicament is particularly useful for treating catabolism caused by glucocorticoid excess.
Career Highlights
Throughout her career, Vibeke has worked with prominent companies in the pharmaceutical industry, including Pharmacia & Upjohn and Chiron Corporation. Her work has been instrumental in advancing therapeutic options for patients facing challenges related to protein metabolism.
Collaborations
Vibeke has collaborated with esteemed colleagues such as Anna Skottner and Kjell Malmlof, contributing to a rich exchange of ideas and innovations in her field.
Conclusion
Vibeke Arrhenius-Nyberg's work exemplifies the impact of innovative thinking in medicinal chemistry. Her patents and collaborations continue to influence the development of effective treatments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile